# Diabetes Therapy

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/diabetes-therapy/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 6,850 |
| Citations | 37,830 |
| h-index | 76 |
| Homepage | https://www.springer.com/journal/13300 |
| Open Access | true |
| ISSN-L | 1869-6953 |
| ISSNs | 1869-6953,1869-6961 |
| OpenAlex ID | https://openalex.org/S16535137 |
| Publisher | Adis, Springer Healthcare |
| Works | 1,898 |

## Journal papers

Showing 12 of 24.

- [Adherence to Therapies in Patients with Type 2 Diabetes](https://scholariq.org/papers/adherence-to-therapies-in-patients-with-type-2-diabetes/)
- [Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review](https://scholariq.org/papers/insulin-therapy-in-adults-with-type-1-diabetes-mellitus-a-narrative-review/)
- [Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial](https://scholariq.org/papers/empagliflozin-improves-liver-steatosis-and-fibrosis-in-patients-with-non/)
- [A Systematic Review of the Direct Economic Burden of Type 2 Diabetes in China](https://scholariq.org/papers/a-systematic-review-of-the-direct-economic-burden-of-type-2-diabetes-in-china/)
- [Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes](https://scholariq.org/papers/real-world-evaluation-of-glp-1-receptor-agonist-therapy-persistence-adherence/)
- [Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review](https://scholariq.org/papers/epidemiology-and-economic-burden-of-cardiovascular-disease-in-patients-with-type/)
- [Physical Activity Levels and Diabetes Prevalence in US Adults: Findings from NHANES 2015–2016](https://scholariq.org/papers/physical-activity-levels-and-diabetes-prevalence-in-us-adults-findings-from/)
- [Comparison of Body Mass Index and Waist Circumference in the Prediction of Diabetes: A Retrospective Longitudinal Study](https://scholariq.org/papers/comparison-of-body-mass-index-and-waist-circumference-in-the-prediction-of/)
- [Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK](https://scholariq.org/papers/understanding-reasons-for-treatment-discontinuation-attitudes-and-education/)
- [Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease](https://scholariq.org/papers/cost-effectiveness-analysis-of-empagliflozin-in-comparison-to-sitagliptin-and/)
- [Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model](https://scholariq.org/papers/cost-effectiveness-of-canagliflozin-added-to-standard-of-care-for-treating/)
- [The Economic Burden of Insulin-Related Hypoglycemia in Spain](https://scholariq.org/papers/the-economic-burden-of-insulin-related-hypoglycemia-in-spain/)

## Journal top topics

Showing 8 of 25.

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Diabetes Management and Education](https://scholariq.org/topics/diabetes-management-and-education/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.